click below
click below
Normal Size Small Size show me how
Cell Signaling II
| Question | Answer |
|---|---|
| What are the two main types of enzyme coupled receptors? | RTK (receptor is kinase enzyme) and cytokines (receptor-protein) |
| Typical characteristics of RTKS: 1. They have a large ______ responsible for binding to _____ | ectodomain, ligands |
| Typical characteristics of RTKS: 2. They have a ________ side with a ___________ | cytoplasmic, tyrosine-kinase domain |
| Typical characteristics of RTKS: 3: undergo structural changes to activate the _________ domain | tyrosine-kinase |
| Typical characteristics of RTKS: 4: Outside of cell, can either have a ________-rich domain or a _____ like domain | cysteine, immunoglobulin |
| When a RTK is activated, what happens? | cross-phosphorylation occurs between kinase domains on two individual TRK domains |
| Where does the signal molecule bind on a TRK domain? | On the non-cytosolic side, to two different TRKS |
| What is the importance of phosphorylated domains? | They are where intracellular signaling proteins bind |
| How many sites are on a PDGF receptor | 5 sites |
| Name three things that bind to PDGF | 1. PI-3 kinase 2. GAP 3. Phospholipase C-gamma |
| Three ways a signal can be transduced: 1. binding to a _________ site 2. direct intreaction of ______ 3. binding to a ________ in the membrane | 1. phosphorylated 2. protein domains 3. phospholipid |
| Signaling through Ras (1-6) are the upstream and 6-8 are downstream | 1. Boss 2. Sev RTK 3. DrK 4. Ras-GEF 5. Ras 6. Raf 7. Mek 8. ErK |
| What are the downsteam components in Ras pathway called? | MAP kinase pathway |
| What are the two possible outcomes of the MAP kinase pathway? | protein changes or gene expression changes |
| What is the purpose of a scaffold protein? | Holds intracellular proteins in place as part of downstream signaling. Directly attacked to receptor |
| The first yeast signaling involving scaffolds involves _______ and the second involves ______ synthesis | mating response, glycerol |
| Mating response pathways involve: | Kinases A,B,C and GPCR |
| Glycerol synthesis pathways involve: | Kinases A,D and a scaffold domain with kinase domain, osmailarity-sensing receptor |
| While a mating factor will initiate the mating repsonse pathway, what initiates the glycerol synthesis pathway? | high osmolarity |
| phosphoinositides occur when ___________ phosphorylates a __________ molecule | activated receptor, phospholipid |
| What bind to phosphoinositides? | Activated intracellular proteins |
| What is the significance of phosphoinositides, and name one for example | They are a part of the signaling pathway, i.e. PIP3 (not PIP2, which is the GPCR pathway) |
| PIP2 leads to the activation of _____ | PKC |
| PIP3 leads to the activation of _____ | PKB(Akt) |
| When PIP3 is created, these two proteins can bind to them | PDK1 and Akt(PKB) |
| This kinase phosphorylates the Akt(PKB) | mTOR |
| An active Akt(PKB) plays a role in the phosphorylation of this | Bad |
| Bad, when active, is bound to this | an inactive apoptosis-inhibitory protein |
| When Bad is inactive, this means that the apoptosis inhibitory protein is | Active |
| What does the apoptosis inhibitor do? | it saves the cell/keeps it from dying etc. |
| What subunit is a major link between GPCR and RTK pathways? | Phospholipase C (either beta or gamma) |
| The cytokine receptors are bound to _____ | kinases |
| The name of the cytokine-bound receptors are called ___ | JAK |
| Two cytokine receptors bind to just one _______ and ________ each other | cytokine, cross-phosphorylate |
| The proteins that are phosphorylated are ________ | tyrosine |
| Phosphorylated sites act as places for these two things to bind | STAT1 and STAT2 |
| What happens after the STATs bind? | JAK phosphorylates them |
| Phosphorylated JAKS _______ from the receptors, ______ via their SH2 domain, and enter the ____ | dissociate, dimerize, nucleus |
| In the nucleus, the JAK dimer binds to the _____ to initiate ______ | DNA, gene transcription |
| An example of a cytokine ligand is | Epo |